KCS Wealth Advisory’s Hologic HOLX Stock Holding History

KCS Wealth Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,762	Closed	-$89K	–	245
2019 Q3	$89K	Buy	+1,762	New	+$86.7K	0.06%	209

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

KCS Wealth Advisory's HOLX Position: Q4 2019 in Review

KCS Wealth Advisory sold out of Hologic (HOLX) in Q4 2019, closing a stake of 1,762 shares — an estimated $89K sold.

KCS Wealth Advisory first reported a position in HOLX in Q3 2019 and held it in 1 quarter. The position peaked at $89K in Q3 2019. 519 funds tracked by Wall St. Rank hold HOLX as of Q4 2019.

KCS Wealth Advisory reported no remaining Hologic position as of Q4 2019 after selling out during the quarter.
KCS Wealth Advisory sold 1,762 Hologic shares in Q4 2019, an estimated $89K.
KCS Wealth Advisory first reported a position in Hologic in Q3 2019 and held it in 1 quarter.
KCS Wealth Advisory's Hologic position peaked at $89K in Q3 2019.
519 funds tracked by Wall St. Rank held Hologic as of Q4 2019.

Based on KCS Wealth Advisory's 13F filing for Q4 2019, filed 15 Jan 2020.